Article (Faculty180)

• 2026

  DSTYK predicts Chemoresistance in Triple-Negative Breast Cancer Patient-Derived Xenograft Models.  Research square. 
• 2025

  Engineered exosomes: a promising drug delivery platform with therapeutic potential.  Frontiers in molecular biosciences.  12:1583992.
• 2024

  PKIB, a Novel Target for Cancer Therapy.  International journal of molecular sciences.  25.
• 2023

  The application of radionuclide therapy for breast cancer.  Frontiers in nuclear medicine.  3:1323514.
• 2022

  The application of exosomes in the treatment of triple-negative breast cancer.  Frontiers in molecular biosciences.  9:1022725.
• 2021

  The contribution of endothelial-mesenchymal transition to atherosclerosis.

  .  International Journal of Translational Medicine.  1:39-54.
• 2021

  DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells.  Cells.  11.
• 2021

  The role of disabled-2 (Dab2) in diseases.  Gene.  769:145202.
• 2021

  Wnt2 Contributes to the Development of Atherosclerosis.  Frontiers in cardiovascular medicine.  8:751720.
• 2020

  DSTYK Promotes Metastasis and Chemoresistance EMT in Colorectal Cancer.  Frontiers in pharmacology.  11:1250.
• 2016

  Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-β-induced autophagy.  Nature cell biology.  18:851-63.
• 2016

  Disabled-2; an autophagic and apoptotic switch.  Cell cycle (Georgetown, Tex.).  15:3319-3320.
• 2015

  Lysophosphatidic acid improves porcine oocyte maturation and embryo development in vitro.  Molecular reproduction and development.  82:66-77.
• 2012

  Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin.  The EMBO journal.  31:2336-49.
• 2011

  Central role for disabled-2 in mesenchymal stem cardiac protein expression and functional consequences after engraftment in acute myocardial infarction.  Stem cells and development.  20:681-93.
• 2009

  Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions.  Oncogene.  28:2999-3007.
• 2008

  The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin.  Oncogene.  27:1865-75.
• 2007

  Probability of the site juxtaposition determines the rate of protein-mediated DNA looping.  Biophysical journal.  93:2726-31.
• 2005

  Nonequivalence of the nucleotide binding domains of the ArsA ATPase.  The Journal of biological chemistry.  280:9921-6.
• 2003

  Communication over a large distance: enhancers and insulators.  Biochemistry and cell biology = Biochimie et biologie cellulaire.  81:241-51.
• 2003

  Rationally designed insulator-like elements can block enhancer action in vitro.  The EMBO journal.  22:4728-37.